Study Stopped
Blinded interim analysis resulted in early termination of the study.
Study of Catheter-related Infections Using Antibiotic-coated Versus Conventional Catheters in Children
A Randomized, Controlled Trial of Catheter Related Infectious Event Rates Using Antibiotic-impregnated Catheters vs. Conventional Catheters in Pediatric Cardiovascular Surgery Patients
1 other identifier
interventional
326
1 country
1
Brief Summary
The primary purpose of the study is to determine if a therapeutic difference exists between central venous catheters impregnated with minocycline and rifampin and conventional catheters not impregnated with antibiotics when used in children at high risk for bloodstream infections (CABSI) after cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Sep 2006
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 28, 2006
CompletedFirst Posted
Study publicly available on registry
August 30, 2006
CompletedStudy Start
First participant enrolled
September 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2010
CompletedResults Posted
Study results publicly available
February 24, 2016
CompletedFebruary 24, 2016
January 1, 2016
3.7 years
August 28, 2006
October 19, 2015
January 27, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of Catheter-related Bloodstream Infections (CRBSI) Per 1000 Catheter Days
Rates of CRBSI defined as 1. micro-organism isolated from a blood culture; 2. Clinical manifestations of infection such as fever (≥38 C) and/or hypotension (defined according to age-related practice guidelines for systolic blood pressure); 3. No apparent source for the bloodstream infection except for the catheter.
Participants were followed for the duration of the hospital stay, an average of 6 days.
Secondary Outcomes (2)
Episodes of Clinical Sepsis and/or Infection With Identified Source Other Than Catheter
Participants were followed for the duration of hospital stay, an average of 6 days.
Death
Participants were followed for the duration of the hospital stay, an average of 6 days.
Study Arms (2)
Antibiotic-impregnated Catheters (M/R)
ACTIVE COMPARATORInterventions is insertion intra-operatively of catheters impregnated with minocycline and rifampin to determine if their is a therapeutic difference between this catheter and the placebo (non-impregnated) catheter. The catheters are sized to accommodate children in different size ranges: Cook Inc. Double Lumen 4 Fr., 8 cm long, (C-UDLM-401J-ABRM-HC), 5 Fr., 8 cm long, (C-UDLM-501J-ABRM-HC), and 5 Fr., 12 cm long, (C-UDLMY-501J-RSC-ABRM-HC).
Non-impregnated Catheter (C/S)
PLACEBO COMPARATORIntervention is insertion intra-operatively of conventional, non-impregnated catheters. There are two sizes to accommodate children in different size ranges: Cook Incorporated Double Lumen Polyurethane Central Venous Catheters, 4 Fr., 8 cm long, (C-UDLM-401J), 5 Fr., 8 cm long, (C-UDLM-501J), and 5 Fr., 12 cm long (C-UDLM-501J-RSC).
Interventions
Patients randomized to this arm will have the antibiotic-impregnated catheters inserted intra-operatively. The catheters are sized to accommodate children in different size ranges.
Patients randomized to this arm will have the central venous catheter inserted intra-operatively. The catheters are sized to accommodate children in different size ranges.
Eligibility Criteria
You may qualify if:
- Age \< 18 years
- Cardiovascular surgery patient with a case complexity warranting CVC placement longer than 3 days
- Study devices of appropriate size for patient use without modification
- Informed consent obtained prior to patient entering the operating room
You may not qualify if:
- Age ≥ 18 years
- Drug allergy to minocycline, other tetracyclines, or rifampin
- Ventricular assist device (VAD) therapy
- Extracorporeal membrane oxygenation (ECMO) therapy
- Patients undergoing cardiac transplant
- Any active infection or being treated for bacteremia at the time of randomization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Riley Hospital for Children
Indianapolis, Indiana, 46202, United States
Related Publications (1)
Cox EG, Knoderer CA, Jennings A, Brown JW, Rodefeld MD, Walker SG, Turrentine MW. A Randomized, Controlled Trial of Catheter-Related Infectious Event Rates Using Antibiotic-Impregnated Catheters Versus Conventional Catheters in Pediatric Cardiovascular Surgery Patients. J Pediatric Infect Dis Soc. 2013 Mar;2(1):67-70. doi: 10.1093/jpids/pis066. Epub 2012 Jul 4.
PMID: 26619445RESULT
Limitations and Caveats
A blinded interim analysis by an independent Data Safety Monitoring Board resulted in early termination of the study: of 288 evaluable patients, the rates of CRBSI and line-related complications were similar between the 2 groups.
Results Point of Contact
- Title
- Elaine G Cox, MD
- Organization
- Riley Hospital for Children
Study Officials
- PRINCIPAL INVESTIGATOR
Elaine G. Cox, MD
Indiana University School of Medicine
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 28, 2006
First Posted
August 30, 2006
Study Start
September 1, 2006
Primary Completion
May 1, 2010
Study Completion
May 1, 2010
Last Updated
February 24, 2016
Results First Posted
February 24, 2016
Record last verified: 2016-01
Data Sharing
- IPD Sharing
- Will not share